Feasibility Study of a New Immunoglobulin E (IgE) Assay Method

RecruitingOBSERVATIONAL

Enrollment

1,376

Participants

Timeline

Start Date

April 20, 2021

Primary Completion Date

January 7, 2026

Study Completion Date

January 7, 2026

Conditions

Allergy and Immunology

Interventions

BIOLOGICAL

collection of blood and urine

blood and urine will be collected during a blood test scheduled for the follow-up of the patient

Trial Locations (2)

RECRUITING

University Hospital, Toulouse

RECRUITING

Larrey hospital, Toulouse

All Listed Sponsors

lead

University Hospital, Toulouse

OTHER

NCT04751760 - Feasibility Study of a New Immunoglobulin E (IgE) Assay Method | Biotech Hunter | Biotech Hunter